EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Comparative Study of Efficacy and Safety of Dapagliflozin vs Basal Insulin in Stabilizing Glycemic Variability in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Triple Drug Combination Therapy

Deepak S Bhosle, Bhakti Chandekar, Satish Shelke

Journal of The Association of Physicians of India · 2025

DOI: 10.59556/japi.73.0925 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of The Association of Physicians of India, 2025. Verfasst von Deepak S Bhosle und 2 weiteren Autor:innen. Beteiligte Einrichtung: Consultant Diabetologist and Professor and Head, Department of Pharmacology, Mahatma Gandhi Mission Medical College, Chhatrapati Sambhajinagar, Mahar…. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Diabetes Mellitus, Type 2, Glucosides, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsDiabetes Mellitus, Type 2GlucosidesHypoglycemic AgentsInsulin GlargineSodium-Glucose Transporter 2 InhibitorsHumansMaleMiddle AgedFemaleBlood GlucoseDrug Therapy, CombinationProspective StudiesGlycated HemoglobinAdultTreatment OutcomeAged

Substanzen

dapagliflozinBenzhydryl CompoundsGlucosidesHypoglycemic AgentsInsulin GlargineBlood GlucoseGlycated HemoglobinSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Consultant Diabetologist and Professor and Head, Department of Pharmacology, Mahatma Gandhi Mission Medical College, Chhatrapati Sambhajinagar, Maharashtra, India.
  • Assistant Professor, Department of Pharmacology, Mahatma Gandhi Mission Medical College, Chhatrapati Sambhajinagar, Maharashtra, India, Corresponding Author.
  • Assistant Professor, Department of Pharmacology, Mahatma Gandhi Mission Medical College, Chhatrapati Sambhajinagar, Maharashtra, India.

Zitieren

APA

Bhosle, D. S., Chandekar, B., & Shelke, S. (2025). Comparative Study of Efficacy and Safety of Dapagliflozin vs Basal Insulin in Stabilizing Glycemic Variability in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Triple Drug Combination Therapy. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.73.0925

Vancouver

Bhosle DS, Chandekar B, Shelke S. Comparative Study of Efficacy and Safety of Dapagliflozin vs Basal Insulin in Stabilizing Glycemic Variability in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Triple Drug Combination Therapy. Journal of The Association of Physicians of India. 2025. doi:10.59556/japi.73.0925

BibTeX
@article{Bhosle2025,
  author = {Bhosle, Deepak S and Chandekar, Bhakti and Shelke, Satish},
  title = {Comparative Study of Efficacy and Safety of Dapagliflozin vs Basal Insulin in Stabilizing Glycemic Variability in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Triple Drug Combination Therapy},
  journal = {Journal of The Association of Physicians of India},
  year = {2025},
  doi = {10.59556/japi.73.0925}
}
Kostenlos starten →